Aumet Raises $12M Series A for AI Health Procurement

Saudi Arabia-based healthtech innovator, Aumet, has successfully closed a $12 million Series A funding round, signaling a significant advancement in its mission to revolutionize healthcare supply chain intelligence. The investment was spearheaded by Emkan Capital, with substantial backing from a consortium of prominent investors including Qatar Development Bank (QDB), SABAH VC, and AAIC. Existing supporters, Shorooq Partners and Right Side Capital Management, also participated, underscoring continued confidence in Aumet's trajectory.

Founded in 2016, Aumet has rapidly established itself as a leader in developing an AI-first procurement operating system tailored for healthcare providers and pharmacies. The company's platform addresses critical inefficiencies within the healthcare ecosystem, moving beyond simple transaction facilitation to offer intelligent decision-making tools. This latest capital infusion is earmarked for accelerating the expansion of its artificial intelligence capabilities, driving enterprise-level deployments, and broadening its regional footprint across the GCC and into international markets.

Aumet's platform has already demonstrated impressive scale, processing over 5 million transactions annually and connecting more than 12,000 pharmacies across Jordan, Egypt, and Saudi Arabia, alongside over 1,000 pharmaceutical suppliers. The company has achieved a remarkable $1 billion in Gross Merchandise Value (GMV), highlighting its significant impact on regional healthcare commerce. This growth trajectory is built upon a layered product strategy, evolving from its initial 'Pulse' system for individual pharmacies to 'Chain' for pharmacy chains and now the advanced 'Enterprise' solution for large healthcare systems.

The 'Enterprise' solution represents Aumet's most sophisticated offering, functioning as a cognitive procurement operating system. Its impact is evident in its widespread adoption within Jordan's public healthcare sector, initially deployed at Al-Basheer Hospital, the nation's largest. The system now supports 32 hospitals, over 500 medical centers, and 18+ medical warehouses. This expansion was facilitated through collaboration with the Jordanian Ministry of Health and Ministry of Digital Economy and Entrepreneurship, and a strategic partnership with Abu Dhabi-based AI firm Presight to scale the OS across the public healthcare infrastructure.

The strategic importance of Aumet's technology is amplified by the global challenge of fragmented healthcare supply chains, particularly in emerging markets. While companies like Clarium tackle similar issues in the US, Aumet's localized, data-driven approach is uniquely positioned to address the specific complexities of the Middle East. The company's CEO and Co-founder, Yahya Aqel, emphasized this point, stating, “Healthcare supply chains don’t suffer from lack of supply — they suffer from lack of intelligence.” He further articulated the vision: “At Aumet, we are building the AI-first operating system that powers procurement decisions across the entire healthcare ecosystem... Our ambition is to take what we’ve built in the Middle East and scale it globally.”

The investor confidence in Aumet's vision is robust. Emkan Capital, leading the round, views Aumet as building the foundational operating system for healthcare supply chains in emerging markets. SABAH.fund highlighted the company's strong founder-market fit, deep expertise, and scalable technology. AAIC also expressed pleasure in strengthening their partnership. The round also saw participation from strategic healthcare investors Cigalah Group and Salehiya Trading Company, adding further industry expertise and market access to Aumet's growing network.